Kintara Therapeutics, Inc. announced on February 4, 2022, Keith Murphy submitted his resignation from the Board of Directors of the Company, effective immediately. At the time of his resignation, Mr. Murphy served on the Compensation Committee and Nominating and Corporate Governance Committee of the Board. Mr. Murphy's resignation was not the result of any disagreements with the Company relating to the Company's operations, policies or practices.